Related Experiment Video
Updated: Jul 16, 2026
07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
[Oligodendrogliomas: their morphological characteristics and molecular alterations]
1Departamento de Anatomía Patológica, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Revista De Neurologia
|March 27, 2007
Summary
Distinguishing oligodendrogliomas from astrocytomas can be challenging due to mixed histology. Analyzing chromosome 1p/19q co-deletion status is crucial for accurate classification and predicting treatment response in these brain tumors.
Area of Science:
- Neuro-oncology
- Cancer genetics
- Histopathology
Context:
- Oligodendrogliomas are infiltrating gliomas responding well to therapy, necessitating differentiation from astrocytomas.
- Histological diagnosis can be ambiguous in mixed or hybrid oligodendroglioma morphologies.
- Current immunohistochemistry markers are insufficient for reliable distinction between oligodendrogliomas and astrocytomas.
Purpose:
- To review histological criteria for identifying oligodendroglial tumors.
- To discuss the utility of chromosomal alterations (1p/19q co-deletion) in classifying challenging cases.
- To highlight the prognostic and therapeutic implications of 1p/19q status.
Summary:
- This review covers histological features of oligodendroglial tumors and differential diagnosis from similar brain tumors.
- It explores how 1p/19q co-deletion, detected by FISH or PCR, aids in classifying mixed oligoastrocytic tumors and defining oligodendroglioma subgroups.
- Analysis of 1p/19q status is recommended for all oligodendroglial tumors to identify subgroups with distinct prognoses and treatment responses.
Impact:
- Provides clear diagnostic criteria for oligodendrogliomas.
- Establishes the importance of genetic analysis (1p/19q co-deletion) in neuro-oncology.
- Enables personalized treatment strategies for glioma patients based on genetic profiles.
